Coinfection of SARS-CoV-2 and MTB: how not to miss the wood for the trees.

Autor:	Jacob J; General Medicine, KS Hegde Medical Academy, Mangalore, Karnataka, India., Venkataram R; Department of Pulmonary Medicine, KS Hegde Medical Academy, Mangalore, Karnataka, India rajdocmmc@gmail.com., Hosmane GB; Pulmonary Medicine, KS Hegde Medical Academy, Mangalore, Karnataka, India.
Jazyk:	angličtina
Zdroj:	BMJ case reports [BMJ Case Rep] 2021 Jul 13; Vol. 14 (7). Date of Electronic Publication: 2021 Jul 13.
DOI:	10.1136/bcr-2020-240581
Abstrakt:	Scarce data exist about the coinfection of SARS-CoV-2 and Mycobacterium tuberculosis (MTB). A young woman who was undergoing treatment for multiple sclerosis was brought to our hospital with a COVID-19 positive status. On further evaluation, her chest X-ray showed right upper and mid-zone opacity, which lead to the suspicion of MTB. Her sputum came positive for acid-fast bacilli (AFB) staining and cartridge-based nucleic acid amplification test (CBNAAT) confirmed it, and rifampicin resistance was not detected. She was started on an antitubercular regimen. She was discharged, and by the end of the intensive phase of treatment, her symptoms subsided, but her sputum CBNAAT still showed the presence of TB bacillus. Competing Interests: Competing interests: None declared. (© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu